Adam Kirton, M.D., M.Sc., FRCPC
Karla Fields has more than 30 years of experience in fundraising, strategic partnerships and volunteer recruitment at a variety of influential cultural, charitable and healthcare institutions including the Laguna Art Museum, United Way and the Alzheimer’s Association. She has developed an impressive track record of creating and delivering health education programming focused on enhancing access and outcomes within diverse populations. At the Alzheimer’s Association, Karla successfully designed and implemented expanded programming and outreach aimed at Northern California’s African American population. As a dedicated advocate she has worked with legislators to improve health care policies and increase funding. She has served as a board member of the Lakeshore Foundation, a nationally recognized paralympic training center, and has led a broad range of community advisory committees. Many of her volunteer efforts have been dedicated to health care challenges faced by children. Anchored in her family’s personal health journeys, she has been a trusted advisor to other families experiencing similar health issues as well as to the institutions seeking to increase the effectiveness of their efforts.
Garry Cutter, Ph.D.
Dr. Cutter is Professor Emeritus of Biostatistics at UAB. He has directed numerous coordinating centers. He is a member of numerous DSMBs and advisory committees for NIH, Pharmaceutical Companies and foundations. . He served on the International Clinical Trials Committee of the National MS Society and International Federation of MS Societies for over a decade as well as being on the editorial boards of the Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, the journal Neurology Clinical Practice as a contributing editor and an Associate Editor of Alzheimer’s Disease Translational Research. He is a member of the Statistics Editorial Board for the Journal of the American Society of Nephrology (JASN). He is a past President of the Consortium of MS Centers. He serves as a mentor on numerous K awards, PhD and master’s students and teaches in various national and international short courses.
Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. He has directed numerous coordinating centers of multiple NIH randomized trials: He directed the coordinating center for the Combination Therapy in MS (COMBIRx) Trial; most recently the Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex and the randomized Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis (PREVeNT trial) both NINDS funded studies. He has been the Deputy Director of the Operations Center and Director of the Coordinating Center for Neurofibromatosis Consortium with 7 current ongoing trials. He directed the coordinating center for the NHLBI Chronic Hypertension in Pregnancy (CHAP) and the Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE) clinical trial funded by NHLBI. He was the PI of the completed Trial of Thymectomy plus Prednisone versus Prednisone alone in the treatment of non-thymomatous Myasthenia Gravis (MGTx). He is the immediate past Director of the NARCOMS multiple sclerosis patient registry and the Myasthenia Gravis patient registry. He is the Director, Biostatistics/Bioinformatics Resource (BBR) Core in the O’Brien Center for Acute Kidney Injury Research, UAB-USC (NIDDK), UAB (NIAID) . Served as Associate Director, National Center for High Impact Clinical Trials in Rehabilitation Medicine and currently co-chairs the Data Quality and Analysis Committee for the Molecular Transducers of Exercise (MoTrPac) study.
Kristie Bjornson, Ph.D., P.T., M.S.
Kristie Bjornson, PT, PhD, MS is Professor, Developmental Medicine, Pediatrics, Adjunct Research Professor, Rehabilitation Medicine at the University of Washington, and Seattle Children’s Hospital Research Institute. Clinically, she has over 40 years of clinical experience in settings such as the NICU, public schools, birth-to-three centers, and at Seattle Children’s Hospital. Ms. Bjornson’s doctoral work focused on the assessment of walking activity, health, and quality of life in ambulatory children with cerebral palsy (CP). She was the first to publish community-based walking activity in children with CP. Dr Bjornson’s clinical trial experience includes the randomized trial and meta-analysis of selective dorsal rhizotomy and botulinum toxin-A injection therapy as well as early safety trials for intrathecal baclofen. Ongoing research includes power training combining the Total Gym and treadmill training, a home-based treadmill training study and a project examining the Ankle-Foot Orthoses Footwear Combination (AFO-FC) orthotic management approach for ambulatory children with CP
Kristie F Bjornson, PT, PhD, MS
University of Washington
Seattle Children’s Research Institute
MS CURE-3, PO BOX 5371
Seattle, WA 98145